Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain
Clinical trial NCT06487065 · COMPLETED
Trial details
- NCT number
- NCT06487065
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-17
- Primary completion
- 2024-10-25
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.